Lewes, DE -- (SBWire) -- 10/07/2013 --LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Nestle SA Reg Shs. Ser. B Spons (ADR) (OTCMKTS:NSRGY), Deutsche Telekom AG (ADR) (OTCMKTS:DTEGY), Alkaline Water Company Inc (OTCBB:WTER), Titan Pharmaceuticals, Inc. (OTCBB:TTNP).

Nestle SA Reg Shs. Ser. B Spons (ADR) (OTCMKTS:NSRGY) ended lower -0.80% and complete the day at $68.60. The total number of shares changed hands during the day was 596,436. After opening at $68.76, the stock hit as high as $68.91. However, it traded between $61.50 and $73.90 over the last twelve months.

Nestle SA is a Switzerland-based holding company of the Nestle Group (the Group) and is principally engaged in the development and production of food and beverage.

Has NSRGY Found The Bottom and Ready To Move Up? Find Out Here

Deutsche Telekom AG (ADR) (OTCMKTS:DTEGY) closed yesterday at $15.20, a +1.95% increase. Around 949,868 shares were traded, beating an-average trading volume of 667,427 shares. The company is now valued at around $67.62 billion.

Deutsche Telekom AG operates as an integrated telecommunication company worldwide. The company offers fixed-network services, such as voice and data communication services based on fixed-network and broadband technology; and sells terminal equipment and other hardware, as well as services to resellers

For How Long DTEGY Gloss will Attract Investors? Find out via this report

Titan Pharmaceuticals, Inc. (OTCBB:TTNP) moved +14.63 percent higher at $0.940 and traded between $0.83 and $0.95 after opening the day at $0.84. Its performance over the last five days remained 55.41%, which stands at 46.87% for a month. Going back further than one month, 1-year performance after recent close was -14.55%.

Titan Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing proprietary therapeutics for the treatment of serious medical disorders in the United States. The company offers Fanapt (iloperidone), an atypical antipsychotic for the treatment of schizophrenia. It is involved in developing Probuphine, an investigational subdermal implant for the treatment of opioid dependence.

For How Long TTNP Gloss will Attract Investors? Find out via this report

Alkaline Water Company Inc (OTCBB:WTER) shares fall, losing -8.59 percent to close at $0.500. The stock is down around -16.67% this year and -16.67% for the last 12 months. Around 3.01 million shares changed hands yesterday, higher from an-average trading volume of 2.07 million shares.

The Alkaline Water Company Inc. engages in the production, distribution, marketing, and selling bottled alkaline water in bulk for retail sale. The company offers bottled alkaline water to retail consumers in three-liter and one-gallon volumes under the Alkaline84 brand. Its target retail markets include chain and independent health food stores; grocery stores; convenience stores; drug stores; and the mass retail market.

Will WTER Get Buyers Even After The Recent Rally? Find Out Here

About LeadingStockAlerts
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/